TBCRC45: AVIATOR: A Phase II Study Of Trastuzumab, Vinorelbine, and Avelumab ± PF-05082566 (4-1BB/CD137 Agonist) in HER2+ MBC
Clinical Trial Grant
Awarded By
Johns Hopkins University
Start Date
April 3, 2019
End Date
September 9, 2025
Awarded By
Johns Hopkins University
Start Date
April 3, 2019
End Date
September 9, 2025